Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

World News: . []

SINGAPORE March 26 2018 GLOBE NEWSWIRE -- ASLAN Pharmaceuticals ASLAN (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, toda y annou...

More news and information about ASLAN PHARMACEUTICALS LIMITED

Published By:

Globe Newswire: 02:00 GMT Tuesday 27th March 2018

Published: .

Search for other references to "aslan" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us